Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127290501 | 12729050 | 1 | I | 20160722 | 20160906 | 20160909 | 20160909 | EXP | PHHY2016FR124250 | NOVARTIS | 12.76 | YR | F | Y | 0.00000 | 20160909 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127290501 | 12729050 | 1 | PS | ZOPHREN | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 16 MG, QD | 48 | MG | Y | 20007 | 16 | MG | SOLUTION FOR INFUSION | QD | |||
| 127290501 | 12729050 | 2 | SS | ETOPOPHOS | ETOPOSIDE PHOSPHATE | 1 | Intravenous (not otherwise specified) | 89 MG, BID | Y | 0 | 89 | MG | LYOPHILISATE | BID | |||||
| 127290501 | 12729050 | 3 | SS | LARGACTIL | CHLORPROMAZINE | 1 | Intravenous (not otherwise specified) | 25 MG/5ML, QD | Y | 0 | INJECTION | QD | |||||||
| 127290501 | 12729050 | 4 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | 3.56 G, QD | 11 | G | Y | 0 | 3.56 | G | SOLUTION FOR INFUSION | QD | |||
| 127290501 | 12729050 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 127290501 | 12729050 | 6 | C | FRAGMINE | DALTEPARIN SODIUM | 1 | Unknown | UNK | U | 0 | |||||||||
| 127290501 | 12729050 | 7 | C | FORLAX | POLYETHYLENE GLYCOL 4000 | 1 | Unknown | UNK | U | 0 | |||||||||
| 127290501 | 12729050 | 8 | C | ELUDRIL | CHLORHEXIDINE GLUCONATECHLOROBUTANOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 127290501 | 12729050 | 9 | C | GABAPENTINE | GABAPENTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 127290501 | 12729050 | 10 | C | MESNA. | MESNA | 1 | Unknown | 100 MG/ML, UNK | U | 0 | SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127290501 | 12729050 | 1 | Vomiting |
| 127290501 | 12729050 | 2 | Osteosarcoma |
| 127290501 | 12729050 | 3 | Vomiting |
| 127290501 | 12729050 | 4 | Osteosarcoma |
| 127290501 | 12729050 | 5 | Osteosarcoma |
| 127290501 | 12729050 | 6 | Product used for unknown indication |
| 127290501 | 12729050 | 7 | Product used for unknown indication |
| 127290501 | 12729050 | 8 | Product used for unknown indication |
| 127290501 | 12729050 | 9 | Product used for unknown indication |
| 127290501 | 12729050 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127290501 | 12729050 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127290501 | 12729050 | Anal incontinence | |
| 127290501 | 12729050 | Coma | |
| 127290501 | 12729050 | Encephalopathy | |
| 127290501 | 12729050 | Urinary incontinence | |
| 127290501 | 12729050 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127290501 | 12729050 | 1 | 20160720 | 20160722 | 0 | |
| 127290501 | 12729050 | 2 | 20160722 | 20160722 | 0 | |
| 127290501 | 12729050 | 3 | 20160720 | 20160722 | 0 | |
| 127290501 | 12729050 | 4 | 20160720 | 20160722 | 0 | |
| 127290501 | 12729050 | 5 | 201602 | 201606 | 0 |